Gordon Dyal & Co LLC advised Bristol Myers Squibb on the acquisition of Karuna Therapeutics for a total equity value of $14.0 billion. https://lnkd.in/eUGxcuzZ
Gordon Dyal & Co. Advisory Group LP
Investment Banking
New York, New York 2,731 followers
Gordon Dyal & Co. Advisory Group LP provides its clients with independent advisory services on M&A transactions.
About us
Gordon Dyal & Co. Advisory Group LP provides its clients with independent advisory services on merger and acquisition transactions as well as special situations. The firm's core principles are integrity, discretion, loyalty, and execution excellence. Broker Dealer Services are provided by Gordon Dyal & Co., LLC Gordon E. Dyal founded the firm to build long-term strategic client relationships across multiple industries worldwide. Gordon Dyal & Co. Advisory Group LP distinguishes its client service through judgment, candor, and the team's cumulative investment banking experience.
- Website
-
http://www.gordondyalco.com
External link for Gordon Dyal & Co. Advisory Group LP
- Industry
- Investment Banking
- Company size
- 11-50 employees
- Headquarters
- New York, New York
- Type
- Partnership
- Founded
- 2016
- Specialties
- Mergers & Acquisitions Advisory, Investment Banking, and Anti-Raid Advisory
Locations
-
Primary
Get directions
152 West 57th Street
25th Floor
New York, New York 10019, US
Employees at Gordon Dyal & Co. Advisory Group LP
-
Stefan Grimbacher
Managing Director, Investment Banking | M&A @ Gordon Dyal & Co.
-
Patrick Orzel
Managing Director and Chief Operating Officer at Gordon Dyal & Co.
-
Kevin Xu
Vice President, Investment Banking at Gordon Dyal & Co. Advisory Group LP
-
Tom Velanovich
Vice President at Gordon Dyal & Co. Advisory Group LP